These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3969267)

  • 1. Protective effect of fosfomycin against aminoglycoside ototoxicity.
    Ohtani I; Ohtsuki K; Aikawa T; Sato Y; Anzai T; Ouchi J; Saito T
    ORL J Otorhinolaryngol Relat Spec; 1985; 47(1):42-8. PubMed ID: 3969267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Protective effect of fosfomycin against aminoglycoside induced ototoxicity].
    Ohtsuki K; Ohtani I; Aikawa T; Sato Y; Anzai T; Ouchi J; Saito T
    Nihon Jibiinkoka Gakkai Kaiho; 1983 Dec; 86(12):1487-96. PubMed ID: 6674446
    [No Abstract]   [Full Text] [Related]  

  • 3. Reduction of cisplatin ototoxicity by fosfomycin in animal model.
    Ohtani I; Ohtsuki K; Aikawa T; Anzai T; Ouchi J; Saito T
    ORL J Otorhinolaryngol Relat Spec; 1985; 47(5):229-35. PubMed ID: 4047624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of protective effect of fosfomycin against aminoglycoside ototoxicity.
    Ohtani I; Ohtsuki K; Aikawa T; Sato Y; Anzai T; Ouchi J
    Auris Nasus Larynx; 1984; 11(3):119-24. PubMed ID: 6529372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of the ototoxicity of aminoglycosides. Comparative study of dibekacin, gentamicin and tobramycin].
    Aran JM
    Nouv Presse Med; 1982 Nov; 11(46):3426-31. PubMed ID: 7155851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Can fosfomycin reduce the nephrotoxicity of aminoglycosides?].
    Morin JP; Olier B; Viotte G; Fillastre JP
    Pathol Biol (Paris); 1984 May; 32(5):338-42. PubMed ID: 6739142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ototoxicity of aminoglycoside antibiotics by rapid intravenous injection.
    Ohtani I; Ohtsuki K; Aikawa T; Omata T; Ouchi J; Saito T
    ORL J Otorhinolaryngol Relat Spec; 1982; 44(3):156-69. PubMed ID: 7099580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of fosfomycin on the experimental nephrotoxicity induced by dibekacin.
    Inouye S; Niizato T; Takeda U; Koeda T
    J Pharmacobiodyn; 1982 Sep; 5(9):659-69. PubMed ID: 7153839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative vestibular toxicity of dibekacin, habekacin and cisplatin.
    Caston J; Doinel L
    Acta Otolaryngol; 1987; 104(3-4):315-21. PubMed ID: 3499743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study on the ototoxicity of dibekacin and tobramycin administered by intravenous infusion.
    Ohtani I; Ohtsuki K; Aikawa T; Ouchi J; Nakayoshi T
    Jpn J Antibiot; 1979 Oct; 32(10):990-7. PubMed ID: 513289
    [No Abstract]   [Full Text] [Related]  

  • 11. [Approach to cochleovestibular tolerability of aminoglycosides in man. Demonstration of a methodology apropos of a controlled comparative trial of dibekacin versus gentamicin].
    Vergnon L; Fraisse P; Bismuth A; Bismuth C
    Nouv Presse Med; 1982 Nov; 11(46):3459-62. PubMed ID: 6760123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low ototoxicity and its mechanism of netilmicin.
    Ohtani I; Ohtsuki K; Aikawa T; Sato Y; Anzai T; Ouchi J; Saito T
    ORL J Otorhinolaryngol Relat Spec; 1985; 47(2):84-9. PubMed ID: 3982812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative ototoxicity of ribostamycin, dactimicin, dibekacin, kanamycin, amikacin, tobramycin, gentamicin, sisomicin and netilmicin in the inner ear of guinea pigs.
    Kitasato I; Yokota M; Inouye S; Igarashi M
    Chemotherapy; 1990; 36(2):155-68. PubMed ID: 2311443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of cochlear and vestibular functions of patients treated by dibekacin in an E.N.T. unit].
    Uziel A; Goubert JL
    Nouv Presse Med; 1982 Nov; 11(46):3456-8. PubMed ID: 6984174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Protective effect of fosfomycin against renal accumulation of aminoglycoside antibiotics].
    Fujita K; Fujita HM; Aso Y
    Jpn J Antibiot; 1983 Dec; 36(12):3392-4. PubMed ID: 6674549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mode of protective action of fosfomycin against dibekacin-induced nephrotoxicity in the dehydrated rats.
    Inouye S; Niizato T; Komiya I; Yuda Y; Yamada Y
    J Pharmacobiodyn; 1982 Dec; 5(12):941-50. PubMed ID: 7169607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of topical fosfomycin on polymyxin B ototoxicity.
    Leach JL; Wright CG; Edwards LB; Meyerhoff WL
    Arch Otolaryngol Head Neck Surg; 1990 Jan; 116(1):49-53. PubMed ID: 2153024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental study of the intrauterine ototoxicity of dibekacin].
    Uziel A; Marot M
    Nouv Presse Med; 1982 Nov; 11(46):3432-4. PubMed ID: 7155852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reduction of cisplatin toxicity by fosfomycin in animal models].
    Ohtani I; Ohtsuki K; Aikawa T; Sato Y; Anzai T; Ouchi J; Saito T
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2400-7. PubMed ID: 6541892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of noise and ototoxic drugs at the cellular level in the cochlea: a review.
    Lim DJ
    Am J Otolaryngol; 1986; 7(2):73-99. PubMed ID: 3515985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.